European Archives - Page 325 of 1156 - European Medical Journal

Central Line Bloodstream Infection

Infection leads to an increased rate and duration of hospitalisation, increased treatment costs, and high morbidity and mortality in…

Caregiver Burden, Resilience, and Wellbeing in Cases of SCAR

Severe cutaneous adverse drug reactions (SCAR) are a group of rare but potentially life-threatening conditions that can occur in response…

Endovascular Stenting for Superior Vena Cava Syndrome

Superior vena cava syndrome (SVCS) is a group of clinical manifestations, caused by an obstruction of venous blood flow to the heart…

Prediagnostic Proteomics of Gout: Abstracts from EULAR 2024

A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.

Anti-Ro/SSA Antibodies in Systemic Sclerosis Stratification: Abstracts from EULAR 2024

Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.

VML Health's Nichole Davies on the good, the bad and the ugly in women’s health

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.

Plant-Based Diet Significantly Reduces Emphysema Risk in Young Smokers

A recent study has highlighted the potential of a plant-based diet on reducing the risk of emphysema in young adults with a history of smoking.

Spirometry Results Differ Based on Race-Neutral Questions

Transitioning to race-neutral spirometry reference equations, changes lung function interpretations, potentially impacting treatment for children with chronic lung diseases.

ViiV's Dr Harmony Garges on making a difference in HIV

Dr Harmony Garges, talks to EMJ GOLD about her decision to join the pharmaceutical industry, treating children with HIV and her views on improving access to HIV treatment.

Oritavancin Use In Recurrent Bone Infections by Methicillin-Resistant Staphylococcus aureus

Oritavancin is a novel long-acting lipoglycopeptide that is active against gram-positive micro-organisms, including…